CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
4.720
+0.190 (4.19%)
At close: Feb 13, 2026, 4:00 PM EST
4.700
-0.020 (-0.42%)
After-hours: Feb 13, 2026, 5:43 PM EST

CervoMed Revenue

CervoMed had revenue of $322.57K in the quarter ending September 30, 2025, a decrease of -83.37%. This brings the company's revenue in the last twelve months to $6.16M, down -38.81% year-over-year. In the year 2024, CervoMed had annual revenue of $9.74M with 36.29% growth.

Revenue (ttm)
$6.16M
Revenue Growth
-38.81%
P/S Ratio
6.82
Revenue / Employee
$410,652
Employees
15
Market Cap
43.67M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.74M2.59M36.29%
Dec 31, 20237.14M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 201371.67K-302.88K-80.87%
Dec 31, 2012374.54K-195.93K-34.35%
Dec 31, 2011570.48K530.29K1,319.48%
Dec 31, 201040.19K--
Dec 31, 2009---
Dec 31, 200840.19K-268.57K-86.98%
Dec 31, 2007308.76K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xilio Therapeutics31.80M
Apollomics6.93M
Aligos Therapeutics2.65M
ABVC BioPharma797.92K
Impact BioMedical25.00K
Revenue Rankings